a physician a building location a clinical trial a department
menu
BCM - Baylor College of Medicine

Giving life to possible

Clinical Trials

A Phase 3, Multicenter Study Designed to Evaluate the Efficacy and Safety of a Long Acting HGH Product (Mod-4023) in Adult Subjects With Growth Hormone Deficiency (H-32653)

Patients with growth hormone deficiency due to a pituitary disorder are treated with a weekly self-injection of a long-acting form of growth hormone. If you have questions or wish to participate in this study, please contact our study coordinator, Betsy Staudinger at (713) 873-8772 or email stauding@bcm.edu. For more information see A Phase 3, Multicenter Study Designed to Evaluate the Efficacy and Safety of a Long Acting HGH Product (Mod-4023) in Adult Subjects With Growth Hormone Deficiency.